Ismail A. Walbi
Najran, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Nanoemulgel mediated enhanced skin curcumin penetration/retention for local treatment of cutaneous leishmaniasis: in vitro and in vivo assessment.
Journal: Drug development and industrial pharmacy
Published: March 01, 2025
Status of diabetes mellitus in different regions of KSA and update on its management.
Journal: Frontiers in clinical diabetes and healthcare
Published: August 17, 2024
Predicting Hydroxychloroquine Clearance in Healthy and Diseased Populations Using a Physiologically Based Pharmacokinetic Approach.
Journal: Pharmaceutics
Published: February 16, 2023
Preparation, Characterization and Evaluation of Flavonolignan Silymarin Effervescent Floating Matrix Tablets for Enhanced Oral Bioavailability.
Journal: Molecules (Basel, Switzerland)
Published: January 25, 2023
Recent Progress in Chitosan-Based Nanomedicine for Its Ocular Application in Glaucoma.
Journal: Pharmaceutics
Published: December 14, 2022
Development of a Curcumin-Loaded Lecithin/Chitosan Nanoparticle Utilizing a Box-Behnken Design of Experiment: Formulation Design and Influence of Process Parameters.
Journal: Polymers
Published: August 04, 2022
Physicochemical Characterization of Chitosan-Decorated Finasteride Solid Lipid Nanoparticles for Skin Drug Delivery.
Journal: BioMed research international
Published: May 16, 2022
Effect of chronic hydroxychloroquine use on COVID-19 risk in patients with rheumatoid arthritis and systemic lupus erythematosus: a multicenter retrospective cohort.
Journal: The Journal of international medical research
Published: April 07, 2022
The relationship between hydroxychloroquine plasma concentration and COVID-19 outcomes in rheumatoid arthritis patients in Saudi Arabia.
Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Published: March 11, 2022
Piclamilast mitigates 1,2-dimethylhydrazine induced colon cancer in rats through modulation of Ras/PI3K/Akt/mTOR and NF-κβ signaling.
Journal: Chemico-biological interactions
Published: August 23, 2021
Last Updated: 09/26/2026